Market Closed -
Other stock markets
|
Pre-market 08:40:11 am | |||
25.26 USD | -3.84% | 25.48 | +0.85% |
01:47pm | Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment | MT |
01:44pm | Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment | MT |
Financials (USD)
Sales 2024 * | 59.96B | Sales 2025 * | 62.57B | Capitalization | 143B |
---|---|---|---|---|---|
Net income 2024 * | 6.75B | Net income 2025 * | 9.29B | EV / Sales 2024 * | 3.17 x |
Net Debt 2024 * | 47.04B | Net Debt 2025 * | 41.91B | EV / Sales 2025 * | 2.96 x |
P/E ratio 2024 * |
18.5
x | P/E ratio 2025 * |
13.5
x | Employees | 88,000 |
Yield 2024 * |
6.71% | Yield 2025 * |
6.89% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | +0.73% | ||
1 week | -0.51% | ||
Current month | -8.97% | ||
1 month | -7.91% | ||
3 months | -8.05% | ||
6 months | -17.80% | ||
Current year | -12.26% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 215 M€ | +12.27% | - | |
9.37% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 25.26 | -3.84% | 47,661,411 |
24-04-24 | 26.27 | -0.19% | 24,547,780 |
24-04-23 | 26.32 | +0.23% | 24,297,821 |
24-04-22 | 26.26 | +1.00% | 35,678,657 |
24-04-19 | 26 | +2.40% | 38,372,801 |
Delayed Quote Nyse, April 25, 2024 at 04:01 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.26% | 143B | |
+25.66% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.11% | 233B | |
+5.36% | 201B | |
-9.98% | 193B | |
-6.47% | 144B | |
+0.60% | 123B |
- Stock Market
- Equities
- PFE Stock